The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kirkwood F. Adams

Department of Medicine and Radiology

University of North Carolina Chapel Hill

Chapel Hill

NC 27514

USA

[email]@med.unc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine and Radiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27514, USA. 1997 - 2010
  • University of North Carolina at Chapel Hill, 27599-7075, USA. 1999 - 2002

References

  1. Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure. Adams, K.F., Mehra, M.R., Oren, R.M., O'Connor, C.M., Chiong, J.R., Ghali, J.K., Lenihan, D.J., Dunlap, S.H., Patterson, J.H., Schwartz, T.A., Felker, G.M. Am. Heart J. (2010) [Pubmed]
  2. Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Adams, K.F., Patterson, J.H., Patterson, J.H., Oren, R.M., Mehra, M.R., O'Connor, C.M., Piña, I.L., Miller, A.B., Chiong, J.R., Dunlap, S.H., Cotts, W.G., Felker, G.M., Schocken, D.D., Schwartz, T.A., Ghali, J.K. Am. Heart J. (2009) [Pubmed]
  3. Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure. Adams, K.F., Piña, I.L., Ghali, J.K., Wagoner, L.E., Dunlap, S.H., Schwartz, T.A., Stough, W.G., Mehra, M.R., Felker, G.M., Chiong, J.R., Patterson, J.H., Kim, J., Butler, J., Oren, R.M. Am. Heart J. (2009) [Pubmed]
  4. Biomarker guided therapy for heart failure: focus on natriuretic peptides. Adams, K.F., Felker, G.M., Fraij, G., Patterson, J.H., O'Connor, C.M. Heart. Fail. Rev (2009) [Pubmed]
  5. Systems biology and heart failure: concepts, methods, and potential research applications. Adams, K.F. Heart. Fail. Rev (2009) [Pubmed]
  6. Introduction: biomarkers in heart failure. Adams, K.F. Heart. Fail. Rev (2009) [Pubmed]
  7. Clinical predictors of in-hospital mortality in acutely decompensated heart failure-piecing together the outcome puzzle. Adams, K.F., Uddin, N., Patterson, J.H. Congest. Heart. Fail (2008) [Pubmed]
  8. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Adams, K.F., Fonarow, G.C., Emerman, C.L., LeJemtel, T.H., Costanzo, M.R., Abraham, W.T., Berkowitz, R.L., Galvao, M., Horton, D.P. Am. Heart J. (2005) [Pubmed]
  9. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. Adams, K.F., Patterson, J.H., Gattis, W.A., O'Connor, C.M., Lee, C.R., Schwartz, T.A., Gheorghiade, M. J. Am. Coll. Cardiol. (2005) [Pubmed]
  10. Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?. Adams, K.F. Curr. Cardiol. Rep (2004) [Pubmed]
  11. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure. Adams, K.F. Am. J. Health. Syst. Pharm (2004) [Pubmed]
  12. How should COMET influence heart failure practice?. Adams, K.F. Curr. Heart. Fail. Rep (2004) [Pubmed]
  13. B-type natriuretic peptide: from bench to bedside. Adams, K.F., Mathur, V.S., Gheorghiade, M. Am. Heart J. (2003) [Pubmed]
  14. Clinical benefits of low serum digoxin concentrations in heart failure. Adams, K.F., Gheorghiade, M., Uretsky, B.F., Patterson, J.H., Schwartz, T.A., Young, J.B. J. Am. Coll. Cardiol. (2002) [Pubmed]
  15. Beta-blockers in heart failure: how far have we progressed?. Adams, K.F. Postgrad. Med (2002) [Pubmed]
  16. Translating heart failure guidelines into clinical practice: clinical science and the art of medicine. Adams, K.F. Curr. Cardiol. Rep (2001) [Pubmed]
  17. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Adams, K.F., Sueta, C.A., Gheorghiade, M., O'Connor, C.M., Schwartz, T.A., Koch, G.G., Uretsky, B., Swedberg, K., McKenna, W., Soler-Soler, J., Califf, R.M. Circulation (1999) [Pubmed]
  18. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy. Adams, K.F., Gheorghiade, M., Uretsky, B.F., Young, J.B., Patterson, J.H., Tomasko, L., Packer, M. Am. Heart J. (1998) [Pubmed]
  19. Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery disease. Adams, K.F. Coron. Artery Dis. (1998) [Pubmed]
  20. Patients with mild heart failure worsen during withdrawal from digoxin therapy. Adams, K.F., Gheorghiade, M., Uretsky, B.F., Young, J.B., Ahmed, S., Tomasko, L., Packer, M. J. Am. Coll. Cardiol. (1997) [Pubmed]
 
WikiGenes - Universities